Duran et al[31] have started to map the APOL1 landscape in our country, revealing the relevant presence of the risk alleles in Colombia: from 102 Afro-descendant patients with end-stage renal disease, 37% of patients had APOL1 high-risk genotype and more than 60 individuals had at least 1 risk allele. This evidence concerns the gene APOL1 and stage 5 chronic kidney disease.